All the news

Alessio Gioia awarded the best oral presentation under 40 at the AINP Congress

23 May 2019
Medicine

Alessio Gioia, a former student of the UniSR Biotechnology Degree Course, was awarded the "Best oral presentation" award among young researchers under 40. The scientific committee of the AINP Onlus (Italian Neuropathic Peripheral Association) awarded the prize on the occasion of the annual Meeting of the Association for the Study of the Peripheral Nervous System held in Padua on April 13th.

The title of the presentation by Dr. Gioia is "Unveiling the role of niaspan in peripheral nerve regeneration"; the study illustrated the effects of Niaspan in the regeneration and remyelination processes of the peripheral nervous system in an animal model of hereditary neuropathy.

Dr. Gioia, after obtaining a Bachelor's and Master's Degree in Biotechnology at the Vita-Salute San Raffaele University, is now a fellow at the Neuromuscular Repair Unit, coordinated by Dr. Stefano Previtali.

"This was the first congress in which I presented data orally" says Alessio. “Bringing my data to a conference with the privilege of having an audience of experts in the field was very stimulating and highly educational for me. Being awarded was a personal satisfaction and a great honor, as well as a strong motivational stimulus".

Share news

You might be interested in

Improving cancer treatment through artificial intelligence
Medicine10 November 2021
Improving cancer treatment through artificial intelligence
Research and Innovation on Green related issues: PON 2021 Call for Application
Research28 October 2021
Research and Innovation on Green related issues: PON 2021 Call for Application
Identified a new subset of liver cells: they could be effective against hepatitis B
Medicine01 September 2021
Identified a new subset of liver cells: they could be effective against hepatitis B
Study describes molecular difference between SARS-CoV-2 infections of different severity
Medicine26 August 2021
Study describes molecular difference between SARS-CoV-2 infections of different severity